IDYA
Price
$25.61
Change
+$0.82 (+3.31%)
Updated
Dec 20, 04:59 PM (EDT)
101 days until earnings call
PLRX
Price
$13.22
Change
-$0.08 (-0.60%)
Updated
Dec 20, 04:59 PM (EDT)
73 days until earnings call
Ad is loading...

IDYA vs PLRX

Header iconIDYA vs PLRX Comparison
Open Charts IDYA vs PLRXBanner chart's image
IDEAYA Biosciences
Price$25.61
Change+$0.82 (+3.31%)
Volume$32.17K
CapitalizationN/A
Pliant Therapeutics
Price$13.22
Change-$0.08 (-0.60%)
Volume$82.26K
CapitalizationN/A
IDYA vs PLRX Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. PLRX commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and PLRX is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (IDYA: $25.61 vs. PLRX: $13.21)
Brand notoriety: IDYA and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 219% vs. PLRX: 359%
Market capitalization -- IDYA: $2.21B vs. PLRX: $804.48M
IDYA [@Biotechnology] is valued at $2.21B. PLRX’s [@Biotechnology] market capitalization is $804.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both IDYA and PLRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 4 TA indicator(s) are bullish while PLRX’s TA Score has 4 bullish TA indicator(s).

  • IDYA’s TA Score: 4 bullish, 4 bearish.
  • PLRX’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than PLRX.

Price Growth

IDYA (@Biotechnology) experienced а +1.67% price change this week, while PLRX (@Biotechnology) price change was -0.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.22%. For the same industry, the average monthly price growth was -1.31%, and the average quarterly price growth was +0.77%.

Reported Earning Dates

IDYA is expected to report earnings on Apr 01, 2025.

PLRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-2.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($2.21B) has a higher market cap than PLRX($804M). PLRX (-27.057) and IDYA (-28.021) have similar YTD gains .
IDYAPLRXIDYA / PLRX
Capitalization2.21B804M275%
EBITDA-220.54MN/A-
Gain YTD-28.021-27.057104%
P/E RatioN/AN/A-
Revenue3.92MN/A-
Total Cash920MN/A-
Total Debt18.8MN/A-
TECHNICAL ANALYSIS
Technical Analysis
IDYAPLRX
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 4 days ago
71%
View a ticker or compare two or three
Ad is loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME29.820.82
+2.83%
GameStop Corp
AAPL254.494.70
+1.88%
Apple
SPY591.157.02
+1.20%
SPDR® S&P 500® ETF Trust
BTC.X97755.930000264.976560
+0.27%
Bitcoin cryptocurrency
TSLA421.06-15.11
-3.46%
Tesla

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with GRI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+3.31%
GRI - IDYA
54%
Loosely correlated
-3.90%
PLRX - IDYA
48%
Loosely correlated
-0.68%
PGEN - IDYA
47%
Loosely correlated
+5.07%
ETNB - IDYA
47%
Loosely correlated
+12.94%
RCKT - IDYA
47%
Loosely correlated
+1.85%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with NTLA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-0.68%
NTLA - PLRX
52%
Loosely correlated
+0.83%
CRSP - PLRX
50%
Loosely correlated
+0.83%
RCKT - PLRX
50%
Loosely correlated
+1.85%
BEAM - PLRX
50%
Loosely correlated
+8.04%
PRME - PLRX
49%
Loosely correlated
+3.94%
More